Recovery from natural or experimental Leishmania major infection, the causative agent of cutaneous leishmaniasis, results in development of durable immunity in mice and humans that is manifested as rapid control of parasite replication and resolution of cutaneous lesion after secondary challenge. This form of ''infection-induced'' immunity is thought to occur naturally in endemic areas and is generally considered the gold standard for any effective vaccine against cutaneous leishmaniasis. To determine factors that might heighten or abrogate infection-induced immunity, we investigated the impact of inoculating dead antigen in the form of killed Leishmania parasites to healed mice. We show that inoculation of killed parasites into mice that resolved their primary virulent L. major infection results in rapid and relatively sustained loss of infection-induced immunity. This loss of immunity was not due to the inability of killed parasites to induce inflammatory responses (such as delayed type hypersensitivity), but it was related to their failure to induce robust IFN-␥ response. Furthermore, inoculation of killed Leishmania parasites into healed mice led to rapid expansion of IL-10-producing CD4 ؉ CD25 ؉ Foxp3 ؉ T cells in lymph nodes draining the primary infection site. Treatment with anti-CD25 or anti-IL-10R mAb abolished killed parasiteinduced loss of immunity. Our study suggests that vaccination with killed parasites could predispose naturally immune individuals to become susceptible to new infections and/or disease reactivation. This may account for the lack of efficacy of such vaccines in field trials in endemic regions. These findings have important implications for vaccine design and vaccination strategies against human cutaneous leishmaniasis.
xperimental murine infection with Leishmania major has provided extensive information on the factors that regulate the development and maintenance of CD4 ϩ T-helper (Th) cells in vivo (1) . However, there is still no effective vaccine against human cutaneous leishmaniasis. Several vaccination trials using heat-killed Leishmania parasites in humans have yielded disappointing results (2) . In contrast, several experimental vaccines were effective in murine studies, many of them relying on IL-12 or components that induce IL-12, as adjuvants (3, 4) . However, as with heat-killed human vaccines, the protection often wanes within a short period.
Recovery from natural or experimental Leishmania major infections in humans and mice results in persistence of low numbers of parasites at the primary site of infection (5) and development of durable immunity (6, 7) . IFN-␥-producing CD4 ϩ T cells (8, 9) , whose maintenance is dependent on persistent live parasites (10, 11) , mediate infection-induced immunity. Thus, infection-induced immunity is a gold standard of anti-Leishmania immunity that must be attained by any Leishmania vaccine to be considered effective (12) . Therefore, understanding the factors that control the development, maintenance, and loss of infection-induced immunity is critically important for development of effective vaccines and vaccination strategies against cutaneous leishmaniasis.
Studies show that many individuals in cutaneous leishmaniasis endemic areas display strong leishmanin skin test (LST) and Leishmania-specific granzyme B reactivity (even in the absence of visible cutaneous lesions), strongly reflecting the presence of infection-induced immunity (12, 13) . Our primary goal was to investigate the effect of inoculating killed L. major into such individuals. Therefore, we determined the impact of inoculation of killed, live, and live-attenuated parasites into mice that healed their primary, experimental virulent L. major infection. We show that the secondary immune response recalled by killed and live parasites in healed mice are qualitatively and quantitatively different. Remarkably, killed parasites caused a dramatic expansion of IL-10-producing CD4 ϩ CD25 ϩ Foxp3 ϩ regulatory T cells in the draining lymph nodes (dLNs) of healed mice, resulting in unexpected rapid and sustained loss of infection-induced immunity.
Results

Inoculation of Killed L. major into Immune Mice That Resolved Their Primary L. major Infection Leads to Rapid and Sustained Loss of
Infection-Induced Immunity. C57BL/6 mice that recovered from primary L. major infection developed infection-induced immunity, as evidenced by strong delayed type hypersensitivity (DTH) response and rapid parasite control after secondary L. major challenge (Fig. S1) . Surprisingly, inoculation of killed (but not live) parasites into the footpad (primary infection site) or rump (distant site) of healed mice led to rapid loss of infection-induced immunity, as evidenced by the inability to control secondary L. major challenge (Ͼ10 4 more parasites than live or PBS controls; P Ͻ 0.01; Fig.  1 A and B) . This loss of immunity was observed even when healed mice were challenged at 5 or 10 weeks after killed parasite inoculation ( Fig. 1 A) , suggesting that killed parasite-induced loss of immunity is relatively sustained and unrelated to nonspecific host innate immune response to killed parasite lysates. Interestingly, incorporation of bacillus Calmette-Guérin or cytosine phosphate guanosine oligodeoxynucleotide (CpG ODN), adjuvants that have been shown to enhance cellular immunity in vaccination studies (14) (15) (16) (17) , was insufficient to overcome killed parasite-induced loss of immunity in healed mice (Fig. 1C) , suggesting that the immuneinhibitory effects of killed parasites are very strong and stable. Furthermore, inoculation of killed (but not live) parasites (without secondary virulent challenge) also led to disease reactivation and extensive proliferation of parasites at the primary infection site (Fig.  1D ). Taken together, these results show that inoculation of killed parasites into healed mice leads to rapid, stable, and relatively sustained loss of infection-induced resistance, and this effect is independent of the site of killed parasite inoculation.
Inoculation of Live and Killed Parasites Induces Comparable Early Inflammatory Responses but Leads to Dramatic Differences in the
Quality of Cytokine Recall Responses in Healed Mice. The striking and unexpected loss of resistance after inoculation of killed parasites into healed mice prompted us to investigate the mechanisms involved in this process. Healed mice inoculated with live or killed parasites (without secondary live challenge) developed comparable DTH response at the inoculation sites, and the number of cells in the dLNs was increased Ϸ3-fold (P Ͻ 0.05) over PBS controls (Fig.  S2) . Furthermore, antigen-specific proliferations of cells from the dLNs of healed mice inoculated with killed and live parasites were similar as assessed by vitro carboxyfluorescein diacetate succinimidyl ester (CFSE) dye dilution ( Fig. 2A) .
Given that inoculation of live and killed parasites induced comparable DTH and proliferative responses in healed mice, we hypothesized they would also induce comparable IFN-␥ recall response. Surprisingly, cells from mice inoculated with killed parasites produced 4-to 6-fold less IFN-␥ (P Ͻ 0.05) and 3-to 4-fold more IL-10 (P Ͻ 0.01) upon in vitro restimulation with soluble Leishmania antigen (SLA) compared with those from mice inoculated with live parasites (Fig. 2 B-D) . This pattern of cytokine response was also seen by intracellular cytokine staining, where there was also 2-to 5-fold (P Ͻ 0.05) higher numbers of IFN-␥-producing CD4 ϩ and CD8 ϩ cells in healed mice injected with live parasites (Fig. S2) . Furthermore, the mean fluorescence intensity (MFI) of IFN-␥-producing CD4 ϩ T cells was also significantly different (live, 1564 Ϯ 243 vs. killed, 736 Ϯ 104; P Ͻ 0.05). Taken together, these results show that the natures of secondary antiLeishmania immune responses recalled by live and killed parasites are qualitatively and quantitatively different. (10, (18) (19) (20) , we hypothesized that these cells play a key role in suppressing IFN-␥ recall response and disrupting resistance in healed mice inoculated with killed parasites. The percentage and absolute number of CD4 ϩ CD25 ϩ T cells in the dLNs of healed mice inoculated with killed parasites were 2-to 3-fold higher (P Ͻ 0.05) than those from mice injected with only PBS or live parasites ( Fig. 3 A and B) , and these cells had a significantly higher MFI than those from mice given PBS or live parasites (336 Ϯ 98, 472 Ϯ 78, and 667 Ϯ 104, P Ͻ 0.05, for PBS, live parasites, and killed parasites, respectively). Furthermore, the absolute numbers of CD4 ϩ CD25 ϩ Foxp3 ϩ cells were 2-to 3-fold higher (P Ͻ 0.05) in mice inoculated with killed parasites than in those given PBS or live parasites (Fig. 3C ). In addition, the percentages (Fig. S3 A-C) and absolute numbers (Fig. 3) L. major 7 days later. Whereas treatment with anti-IL-10R mAb had no effect on DTH, mice treated with anti-CD25 mAb had reduced DTH response (Fig. S4A) . Importantly, although mice inoculated with killed parasites and treated with control mAbs lost their immunity and had Ͼ1,000-fold higher parasite burden than their PBS controls (P Ͻ 0.05), mice treated with depleting anti-CD25 (Ͼ85% depletion of CD25 ϩ cells) or anti-IL-10R mAb effectively controlled parasite proliferation (Fig. 4A) . Treatment of naïve mice with anti-CD25 or anti-IL-10R mAbs did not enhance their ability to control parasite burden (Fig. 4B) , suggesting that the effects of these mAbs in healed mice were most likely related to depletion of the expanded CD25 ϩ IL-10 ϩ population after inoculation of killed parasites.
Because healed mice inoculated with killed parasites also had significantly lower numbers of antigen-specific, IFN-␥-producing CD8 ϩ T cells than those injected with live parasites (Fig. S2 ), we investigated whether this inability of killed parasites to recall Leishmania-specific CD8 ϩ T cells contributed in part to the observed loss of infection-induced immunity. Depletion of CD8 ϩ T cells in healed mice before injection with virulent or live-attenuated parasites did not affect the nature of cytokine response or resistance to virulent L. major challenge (Fig. S4 ). Taken together, these results show that increased expansion of IL-10-producing CD4 ϩ CD25 ϩ T cells in healed mice after injection of killed parasites contributes to the loss of infection-induced resistance in these mice. 
Inoculation of Live Avirulent L. major Does Not Induce Expansion of CD4 ؉ CD25 ؉ T Cells and Loss of Infection-Induced Resistance in Healed
Mice. Next, we assessed the impact of two attenuated parasite strains, lpg2 Ϫ L. major (which does not induce pathology but resembles wild-type parasites because it persists indefinitely in infected mice) (21) (Fig. S5A) . However, the percentages and absolute numbers of CD4 ϩ CD25 ϩ cells in the dLNs of mice inoculated with killed parasites were 2-to 3-fold higher (P Ͻ 0.05) than in those injected with virulent (FN) or attenuated (lpg2 Ϫ or dhfr-ts Ϫ ) L. major ( Fig. 5 A and B) . In addition, upon in vitro restimulation with SLA, the percentages of proliferating CD4
ϩ Foxp3 ϩ and CD4 ϩ CD25 ϩ cells were higher in healed mice injected with killed parasites, and these cells underwent more divisions (more shift to the left, 32% vs. 12% for killed and dhfr-ts, respectively) than those from mice injected with live parasites (Fig.  S5 B and C) . Importantly, unlike killed parasites, injection of live-avirulent parasites (lpg2 Ϫ and dhfr-ts Ϫ ) did not result in loss of infection-induced resistance (Fig. 5C ). Taken together, these results suggest that there is something inherent in killed parasites that causes expansion of CD4 ϩ CD25 ϩ Foxp3 ϩ T cells and a concomitant loss of infection-induced resistance in healed mice.
Killed Trypanosoma congolense Does Not Elicit Expansion of CD4 ؉ CD25 ؉ T Cells or Induce Disruption of Immunity in Mice That
Healed Primary L. major Infection. To determine whether expansion of CD4 ϩ CD25 ϩ Foxp3 ϩ T cells in healed mice inoculated with killed L. major is a general property of all killed protozoan parasites or is specific to Leishmania antigen, we inoculated healed mice with killed L. major and a related parasite, T. congolense, and after 3 days we measured DTH response and determined the numbers of CD4 ϩ CD25 ϩ cells in the dLNs. In contrast to killed L. major, which elicited a robust DTH response, killed T. congolense did not elicit significant DTH response in healed mice (Fig. 6A) . Similarly, only mice given killed L. major had 2-to 3-fold elevation (P Ͻ 0.05) in the numbers of CD4 ϩ CD25 ϩ T cells in their dLNs (Fig. 6B ) and were susceptible to virulent L. major challenge (Fig. 6C) , suggesting that the induction of CD4 ϩ CD25 ϩ and loss of infection-induced resistance by killed parasites may be a Leishmania-specific-driven process. Furthermore, only Leishmania antigens (but not T. congolense antigens) were capable of inducing enhanced expression of Foxp3 and IL-10 on cells from the dLNs of healed mice injected with killed L. major, and these cells proliferated vigorously in response to SLA stimulation in vitro (Fig. S6) . Together, these results suggest that the increased numbers of CD4 ϩ CD25 ϩ 
Discussion
In this study, we evaluated the impact of live and killed parasites on immunity acquired after resolution of primary virulent L. major infection. We show that inoculation of killed parasites into immune mice leads to rapid and relatively sustained loss of infection-induced resistance, as evidenced by significantly higher parasite burden upon secondary challenge. Interestingly, the quality of secondary immunity recalled by killed parasites in healed mice was dramatically different from that recalled by live parasites. Live parasites recalled predominantly early and sustained IFN-␥ response, leading to maintenance of infectioninduced immunity. In contrast, killed parasites induced expansion of IL-10-producing CD4 ϩ CD25 ϩ Foxp3 ϩ T cells. Injection of anti-CD25 or anti-IL-10R mAb before inoculation of killed parasites abolished the disruption of infection-induced immunity, implicating regulatory T cells and IL-10 in this process.
To our knowledge, rapid loss of anti-Leishmania immunity in the face of parasite persistence has not been previously described. Loss of infection-induced immunity has been linked previously to manipulations that result in complete parasite clearance (10, 11) . The sustained loss of immunity (Ͼ5-10 weeks) after inoculation of killed parasites suggests this could not have been related to a nonspecific effect of host innate immune response to killed parasites. Indeed, we found that killed and live parasites induced comparable early inflammatory responses in healed ( Fig. 2 A and  Fig. S1 ) and naïve mice (23) . Furthermore, inoculation of killed parasite did not cause clearance of persistent parasites in healed mice, but resulted in expansion of IL-10-producing CD4 ϩ CD25 ϩ Foxp3 ϩ cells, leading to reactivation of primary infection and loss of resistance. Thus, the data presented here indicate that although persistent parasites are necessary, they are by themselves not sufficient to maintain infection-induced immunity in healed animals, particularly in response to killed parasite inoculation. They further suggest that after recovery from primary infection, a critical but delicate balance is established between regulatory T cells and persistent parasites for maintenance of infectioninduced immunity, and perturbing each of these components could lead to sterile cure or loss of immunity and reactivation disease.
The rapid expansion (within 3-7 days) of CD4 ϩ CD25 ϩ cells and coexpression of FoxP3 only in healed mice inoculated with killed but not live virulent or attenuated (lpg2 Ϫ or dhfr-ts Ϫ ) parasites suggest these cells are not derived from activated effector cells responding to their cognate antigen. In addition, the sustained loss of immunity after inoculation of killed parasites indicates the expanded T regs persist over a long period. Furthermore, only Leishmania antigens (but not T. congolense antigens) were capable of inducing expansion in vivo and in vitro of Foxp3 ϩ and IL-10 ϩ cells in healed mice inoculated with killed L. major (Fig. S6) . This is consistent with previous reports showing that T regs from healed mice could be expanded with leishmanial antigen in vitro (19) , are the major producers of IL-10 in L. major-infected mice, and play a critical role in disease reactivation and recrudescence (10) . In contrast, Anderson et al. (24) found CD4 ϩ Tbet ϩ IFN-␥ ϩ cells were the major producers of IL-10 in chronic L. major infection. These discrepancies may be related to differences in parasite strains; Anderson et al. (24) used a strain of L. major that causes chronic, nonhealing disease, whereas we and others used Freidlin, a strain that induces the classic healing disease in C57BL/6 mice. In line with this, previous studies by the same laboratory that used FN implicated CD4 ϩ CD25 ϩ FoxP3 ϩ cells as the major IL-10 producers in infected mice (10) . In addition, our finding that live parasites do not expand T regs differs from that reported by Mendez et al. (18) . Although this report did not examine the effect of killed parasites (making direct comparisons impossible), we think the differences may arise from various technical sources, such as the site studied (primary site vs. dLNs in our study) and/or viability of the parasite inocula. A recent study suggests viability can be a factor in parasite virulence (25). The parasites used in our study were more than 95% viable, whereas this information was not provided by Mendez et al. (18) .
An interesting but surprising finding was the inability of CpG ODN and bacillus Calmette-Guérin to abrogate killed parasiteinduced loss of immunity. In particular, CpG has been shown to act directly on CD4 ϩ T effector cells, thereby making them resistant to suppressive effects of T regs (26) . It is plausible that T regs in our model may be acting directly on infected macrophages to cause their alternative activation, and thereby inhibit their leishmaniacidal ability (27) . In line with this, we found there was no difference in DTH and antigen-specific T-cell proliferation in vitro and in vivo in mice inoculated with killed and live parasites, despite the significant differences in percentages and absolute numbers of regulatory T cells. Alternatively, it is possible that in addition to T regs, other mechanisms contribute to killed parasite-induced loss of immunity.
Several vaccination trials have been conducted in several parts of the world using heat-killed whole Leishmania with or without bacillus Calmette-Guérin as immunogen, with disappointing results (15, 28) The failure of heat-killed Leishmania vaccine to induce significant protection or durable immunity has been attributed to its inability to induce sustained anti-Leishmania memory cells (3, 29) . Many people in endemic regions who would be classified as healthy likely have asymptomatic infections through exposure to L. major naturally by infected sand fly bite. A greater number of these individuals will present little or no evidence of clinical disease and will subsequently develop strong infectioninduced resistance (akin to our healed mice) (13, 30) . As in mice, primary infection with L. major in humans results in persistence of parasites and accumulation of natural regulatory T cells at the site of infection (31) . Therefore, vaccinating these individuals with heat-killed L. major could lead to expansion of these Leishmaniaspecific T regs, which could abolish the induction of protective immunity or result in loss of natural infection-induced resistance, thereby rendering these individuals susceptible to new infections or reactivation of latent infections. Although mice inoculated with killed parasites showed some protection over naïve mice when challenged after 10 weeks, the complete loss of immunity (at 2 and 5 weeks) and significantly impaired protection at 10 weeks indicate there is a window when exposure to killed parasites leads to complete or partial breakdown of immunity, which could predispose to susceptibility to new infections.
In summary, we have shown that inoculation of killed L. major into healed mice leads to a rapid expansion of IL-10-producing CD4 ϩ CD25 ϩ cells resulting in rapid and sustained loss of infectioninduced resistance. A proposed model to explain this loss of resistance is presented in Fig. S7 . Although the effects of killed parasites have not been tested in humans, it is conceivable that vaccination with heat-killed Leishmania could produce similar effects, particularly in endemic areas where many people with subclinical infections (LST ϩ ) akin to infection-induced resistance in mice exist.
Materials and Methods
Mice. Female C57BL/6 mice (6 -8 weeks old) were obtained from the University of Manitoba Central Animal Care Services breeding facility. All mice were maintained in a specific pathogen-free environment, and all experiments were approved by institutional ethics committee in accordance with the Canadian Council for Animal Care guidelines.
Parasites and Infections (Primary and Challenge Infections). L. major parasites
[MHOM/IL/80/Friedlin (FN)] were grown in Grace insect medium (Invitrogen, Life Technologies) supplemented with 20% heat-inactivated FBS, 2 mM L-glutamine, 100 units/mL penicillin, 100 g/mL streptomycin, and 25 mM Hepes (complete parasite medium). The strains and method of derivation of the attenuated (avirulent) LPG2-deficient L. major (lpg2 Ϫ ) and conditional auxotrophic L. major, (dhfr-ts Ϫ ) have been described previously (21, 22) . The dhfr-ts parasites were grown in complete parasite medium supplemented with 10 M thymidine and 10 g/mL hygromycin B and G418; lpg2 Ϫ parasites were grown in 10 g/mL hygromycin B. For primary infections, mice were injected in the right hind footpads with 2 ϫ 10 6 stationary-phase promastigotes (FN; greater than 95% viable by propidium iodide exclusion test). Killed parasites were prepared by either autoclaving (15, 28) or by repeated freeze-thawing [five cycles of alternating Ϫ80°C (freezing) for 1 h, followed by 1 h at room temperature (thawing)]. For challenge infections, age-matched naïve or healed mice were first inoculated with either PBS, killed, live-avirulent (lpg2 Ϫ or dhfr-ts Ϫ ), or virulent (FN) L. major (5 ϫ 10 6 parasite equivalent per mouse) at the primary infection site (right footpad) or rump for 1-10 weeks and then challenged with 5 ϫ 10 6 FN in the contralateral (left) footpad. In some experiments, killed parasites were inoculated together with or without bacillus Calmette-Gué rin (10 5 cfu, kindly provided by Xi Yang, Department of Medical Microbiology, University of Manitoba) or Class 1B CpG ODN 1826 (100 g/mouse; Coley Pharmaceuticals) or with autoclaved or freezethawed T. congolense clone TC13 (5 ϫ 10 6 parasite equivalent, kindly provided by Henry Tabel, Department of Veterinary Microbiology, University of Saskatchewan, Saskatoon, SK, Canada).
Direct ex Vivo Staining for T Regs and IL-10.
At indicated times, mice were killed and the popliteal dLNs were made into single-cell suspensions in complete tissue culture medium (DMEM supplemented with 10% heat-inactivated FBS, 2 mM glutamine, 100 units/mL penicillin, 100 g/mL streptomycin, 25 mM Hepes, and 50 M 2-mercaptoethanol; Invitrogen). The cells were directly stained ex vivo for surface expression of CD4 and CD25 and intracellularly for Foxp3 by using a T reg staining kit (BD Biosciences). In some experiments, the cells were stimulated with phorbol myristic acetate (PMA; 50 ng/mL), ionomycin (500 ng/mL), and brefeldin A (BFA; 10 g/mL) for 5 h and stained intracellularly for IL-10 expression.
Cell Cultures, in Vitro and in Vivo Cellular Proliferation Assays, and Intracellular Cytokine Staining. Single-cell suspensions were cultured in 24-well plates at 4 million cells per milliliter (1 mL per well), with or without SLA (50 g/mL). After 72 h, the supernatant fluids were collected and assayed for cytokines by ELISA, and some cells were then used for intracellular cytokine staining as described previously (32) . Some cells were labeled with CFSE dye as described previously (32) , cultured in 96-well, round-bottom culture plates (2 ϫ 10 5 per well in 200-L aliquots) with SLA or freeze-thawed L. major or T. congolense (10 6 per milliliter) for 5 days, and routinely stained for CD4, CD25, IL-10, and Foxp3 expressions. Stained cells were acquired on a FACSCalibur machine and analyzed by using CellQuest Pro (BD Biosciences).
Cytokine ELISAs. The concentrations of IL-4, IL-10, and IFN-␥ in the culture supernatant fluids were determined by sandwich ELISAs using Ab pairs purchased from BD Biosciences according to the manufacturer's suggested protocols.
DTH Measurement and Determination of Parasite Burden. DTH in the primary or challenge infection site was determined in immune mice inoculated with live or killed L. major parasites at 72 h after inoculation (challenge) by measuring footpad swelling by using digital calipers (Fisher Scientific). Parasite burden was determined by limiting-dilution assay, as described previously (33) .
Depletion of CD25 ؉ Cells and Blockade of IL-10 Signaling in Vivo. Age-matched naïve and healed mice were injected (i.p.) with 100 g of anti-CD25 mAb (PC61) or anti-IL-10R mAb at day Ϫ1 before inoculation with killed parasites and then once weekly for 3 weeks (for anti-IL-10R). Previous dose titration studies indicate this concentration of PC61 mAb was sufficient to deplete between 85% and 95% of CD4ϩCD25 high cells for more than 7 days.
Statistical Analysis. Two-tailed Student's t test was used to compare mean and SEM between two groups. In some other experiments, a one-way ANOVA (nonparametric) was used to compare mean and SEM of more than two groups. Tukey's test was further used when the ANOVA test revealed significant differences. Differences were considered significant at P Ͻ 0.05. . Recovery from virulent L. major infection leads to development of infection-induced resistance. Naïve mice were inoculated in the footpad with L. major and allowed to completely resolve their cutaneous lesions (A). After recovery (complete resolution of cutaneous lesion, Ͼ14 wk after primary infection), healed mice and their age-matched controls were challenged with virulent L. major, and DTH response (B) was measured after 3 days. Challenged mice were killed after 3 weeks to determine parasite burden at the secondary challenge site (C). Error bars show SEM; * , P Ͻ 0.001. 
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